baber/WOPTO huggingface dataset:
Patent IE-42857-B1 (IE)
Title: Fixing pigments on materials in fibre or sheet-like form
IPC: D06P1/52
Filed: 1976-06-11
Abstract: 1504462 Pigment/polymer compositions and fixing process to fibres or sheets CASSELLA FARBWERKE MAINKUR AG I June 1976 [13 June 1975 27 Feb 1976] 22594/76 Heading D1B A binder composition for fixing a pigment (as defined herein) on a material in fibre or sheet-like form, comprises a dispersion or emulsion of a polymer which can be cured to give a water-insoluble coating, containing 0.5-30%, based on the polymer solids, of a salt of a sulphated oleic acid amide of formula where R 1 is H 1 or C 1-6 alkyl; R 2 is H 1 C 1-6 alkyl or phenyl and X is a cation. Also a process for fixing pigments to a material in fibre or sheet-like form comprises applying the above composition and then curing the polymer. Pigments include pigment dyestuffs, disperse and sulphur dyes, colour lakes or water-soluble sulphur dyes. Polymers exemplified are derived from acrylic and methacrylic esters styrene, acrylonitrile, vinyl esters, vinyl ethers, vinylidene chloride, acrylic acid, methacrylic acid, acrylamide, methacrylamide and butadienes. The composition preferably also contains curing agents and other additives. Materials exemplified are based on natural or regenerated cellulose, acetylated cellulose, wool, silk, polyamide, polyester, polyacrylonitrile, polyvinyl chloride, polyvinyl alcohol, glass, or asbestos fibres. Pigment dyeings or prints on paper carboard and films of all types can also be produced. After application the binders are fixed usually by heating or steaming.
Patent IE-33318-B1 (IE)
Title: Intestinal bile acid binding process and compositions
IPC: A61K9/14
Filed: 1969-09-15
Abstract: 1,262,556. Bile-acid binding compositions. BRISTOL-MYERS CO. 19 Sept., 1969 [20 Sept., 1968], No. 46240/69. Heading A5B. A composition for binding bile-acid in the digestive tract of a taurine/bile acid conjugatesecreting animal (or human) comprises a non- toxic, bile-acid binding anion exchange resin and taurine or a salt or a precursor thereof (e.g. cysteine, cysteine-sulphinic acid, hypotaurine and methionine). The preferred resin is cholesstyramine; others mentioned include polystyrene resins cross-linked with divinyl benzene and containing amino acid addition salt or quaternary ammonium exchange groups, certain cellulose and dextran derivatives and polyethylene imine resins. The invention also comprises the treatment of non-human animals for the above-mentioned purpose by concamitantly administering thereto the resin and taurine or taurine derivative.
[GB1262556A]
Patent IE-37514-B1 (IE)
Title: Benzodiazepine derivatives
IPC: A61P31/04
Filed: 1972-10-13
Abstract: Novel derivatives of 3H-1,5-benzodiazepine and of their salts of addition with acids, including their quaternary ammonium salts, having the general formula: S-X-R2 ¦ N = C ANGLE ANGLE CH2(I) N = C ----- are provided. Such compounds are effective therapeutically against a large spectrum of gram positive bacteria and APR8 influenza virus. The invention also provides a novel method of preparing compounds having the formula: S PARALLEL N--C ANGLE ANGLE CH2 (III) N=C ----- wherein R and R' are the same as above, by reacting orthophenylenediamine with a benzoyldithioacetic acid having the formula: S ----CO-CH2-C ANGLE (II) SH wherein R and R' are as defined above.
[US3933793A]
Patent IE-61820-B1 (IE)
Title: Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
Inventor: DELESPESSE GUY
IPC: C07K16/00
Filed: 1986-06-10
Abstract: The invention relates to novel purified human immunoglobulin E binding factors (lgE-BFs), its individual optionally glycosylated proteins, and fragments thereof, processes for the purification of IgE-BFs, novel monoclonal antibodies to lymphocyte cellular receptors for IgE (Fc,R) crossreacting with IgE-BFs, derivatives thereof, processes for the preparation of these antibodies and their derivatives, hybridoma cell lines that produce these antibodies, processes for the preparation of said hybridoma cell lines, the use of the monoclonal antibodies and their derivatives forthe qualitative and quantitative determination of IgE-BFs, test kits containing the monoclonal antibodies and/or their derivatives, the use of the monoclonal antibodies for the purification of lgE-BFs, the use of purified IgE-BFs, its individual optionally glycosylated proteins andlor fragments thereof for the prevention and/ortreat- ment of allergy, and to pharmaceutical preparations containing them. IgE-BFs and monoclonal antibodies reacting with IgE-BF are important for the diagnosis and therapy of allergic diseases.
Patent IE-48399-B1 (IE)
Title: Live attenuated human hepatitis-a-virus,method for growing it in cell culture in vitro and composition comprising it
IPC: A61K39/29
Filed: 1979-08-16
Abstract: Hepatitis A virus is passaged at least once in a susceptible sub-human primate; the infected liver from such passage is used to inoculate an in vitro cell culture, the inoculated cell culture is incubated until hepatitis A antigen is detected in the cell sheet or culture fluid, and at least two serial in vitro passages in cell culture are carried out. The hepatitis A virus so modified can be used to prepare live, attenuated hepatitis A vaccine or an inactivated hepatitis A vaccine.
Patent IE-66911-B1 (IE)
Title: Coated perfume particles
Inventor: SCHMIDT DIANE GROB
IPC: A61K8/00
Filed: 1990-05-10
Abstract: Perfume particles comprise perfume dispersed within certain water-insoluble polymeric carrier materials and encapsulated in a protective shell by coating with a friable coating material. The coated particles allow for preservation and protection of perfumes which are susceptible to degradation or loss in storage and in harsh cleaning conditions. In use, the surface coating fractures and the underlying carrier/perfume particles efficiently deliver a large variety of perfume types to fabrics or other surfaces.
Patent IE-53431-B1 (IE)
Title: Kit for converting a panel opening to a shielded pin receptacle
IPC: H01R13/658
Filed: 1982-07-27
Abstract: A kit is disclosed for converting a standard connector opening 36 in a panel 14 or the like into a shielded pin receptacle. The kit includes a ground plane spring 10 and a shielded header shroud 12. The spring 12 is a planar metal member having spring fingers 20 on the outer periphery and a central opening conforming to the panel opening. A plurality of integral inwardly directed tines 24 surround the central opening and extend substantially normal to the spring 10. The shroud 12 is formed of insulative material with a cavity 28 profiled to receive both the tines 24 and a mating connector 16. An array of openings 30 in the bottom of the cavity permit insertion of pin terminals 60, 68 from a pin header 52, pin connector 56, or the like.
Patent IE-55842-B1 (IE)
Title: Cardiotonic agents
IPC: C07D401/10
Filed: 1983-08-03
Abstract: Certain 2(1H)-pyridinones are disclosed, which can act as cardiotonic agents. The compounds have the general formula I: <CHEM> wherein W, X, Y and Z are various substituents a
[EP0102227A2]
Patent IE-58121-B1 (IE)
Title: 1,3-Disubstituted piperdine compounds as neuroleptic agents
IPC: C07C43/225
Filed: 1985-07-24
Abstract: 1,3-Disubstituted piperidine compounds of the formula 
<CHEM>
 and the pharmaceutically-acceptable acid-addition salts thereof; wherein
 X and Y are each hydrogen, fluoro, chloro or bromo;
 Z is hydrogen, fluoro or chloro;
 Q represents a chemical bond, a divalent group of the formula -C(=O)- or a divalent group of the formula -CH(OH)-;
 and n is an integer from 3 to 5. 
<??>The compounds possess pharmaceutical activity as neuroleptic agents, and they are useful for treating psychotic disorders, e.g. schizophrenia, in human subjects. In particular, they are useful for alleviating such symptoms as anxiety, agitation, excessive aggression, tension and social or emotional withdrawal in psychotic patients. 
<??>Certain 3-(3-methoxyphenyl)-piperidine compounds are useful as chemical intermediates to the aforementioned neuroleptic agents are also described.
Patent IE-75693-B1 (IE)
Title: HIV-inhibiting benzeneacetamide derivatives
Inventor: DAELE GEORGES HENRI PAUL VAN
IPC: C07C205/57
Filed: 1991-06-25
Abstract: A compound for use as a medicine having formula (I), a pharmaceutically acceptable acid addition salt form or a stereochemically isomeric form thereof, wherein R<1> and R<2> each independently are hydrogen, C1-6alkyl or C3-6cycloalkyl; or R<1> and R<2> taken together with the nitrogen atom bearing said R<1> and R<2> may form a pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl or 4-C1-4alkylpiperazinyl group; X is O or S; R<3> is hydrogen or C1-6alkyl; R<4>, R<5> and R<6> each independently are hydrogen, halo, C1-6alkyl, C1-6alkyloxy, nitro, trifluoromethyl, cyano, aminomethyl, carboxyl, C1-4alkyloxycarbonyl, C1-4alkyl-carbonyl, aminocarbonyl or hydroxy; R<7> is hydrogen or halo; and R<8>, R<9> and R<10> each independently are hydrogen, halo, C1-6alkyl, C1-6alkyloxy, nitro, hydroxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, (trifluoromethyl)carbonyl, aminocarbonyl, (cyclopropyl)carbonyl or a radical C1-6alkyl-(C=Y)- wherein =Y represents =O, =N-OH, =N-OCH3, =N-NH2 or =N-N(CH3)2; provided that (1) R<1> is other than n-propyl when R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<9> and R<10> represent hydrogen, R<8> represents 4-ethoxy and X represents oxygen, and (2) X is other than sulfur, when R<1>, R<2>, R<3>, R<6>, R<7>, R<8>, R<9> and R<10> represent hydrogen and R<4> and R<5> represent 3,4-dimethoxy. Novel compounds, pharmaceutical compositions containing said compounds of formula (I), and processes for preparing said compositions.
Patent IE-56181-B1 (IE)
Title: Method for removing impurities from leukocyte interferon preparations,and purified leukocyte interferon produced thereby
IPC: C12P21/02
Filed: 1983-10-28
Abstract: A method of removing oligomers and slow monomer from leukocute interferon (IFN- alpha ) having high sequence homology with human leukocyte interferon which method comprises:
 a) incubating a buffer solution containing 1-20 mg/ml of IFN- alpha  at a pH between 3 and approximately 4.8 for 30 minutes-24 hours at 28-40 DEG C to precipitate oligomers and slow monomer followed by;
 b) recovering native IFN- alpha .
Patent IE-42365-B1 (IE)
Title: Process for the preparation of 4-hydroxy-3-methoxy-phenylacetonitrile
IPC: C07C253/00
Filed: 1975-12-02
Abstract: 1472368 4 - Hydroxy - 3 - methoxy - phenylacetonitrile BAYER AG 21 Oct 1975 [3 Dec 1974] 43104/75 Heading C2C 4 - Hydroxy - 3 - methoxy - phenylacetonitrile is prepared by reacting an N-alkylvanillylamine of the formula in which R is an alkyl group, with hydrogen cyanide at 100‹ to 190‹ C. in water or an inert organic solvent. The hydrogen cyanide may be produced in situ by the action of an acid on an alkali metal or alkaline earth metal cyanide.
Patent IE-44240-B1 (IE)
Title: Improvements in or relating to rotary surface aerators
IPC: C02F3/16
Filed: 1976-12-20
Abstract: 1502742 Aerating liquids SIMON-HARTLEY Ltd 22 Nov 1976 [10 Jan 1976] 00927/76 Heading B1C A rotatable surface aerator has a support member in the form of a flat plate 10 having a plurality of angularly spaced blades 15 secured to its underside, each blade having a maximum depth intermediate its ends and a plate 16 secured to its lower edge and extending on both sides of the blade at least between its outer end and the position of maximum depth. There is preferably a baffle situated beneath the aerator to prevent rotational flow of liquid beneath it; the baffle may consist of four vertical plates forming a cross, see Fig 4. (not shown).
Patent IE-65999-B1 (IE)
Title: Process for producing moldings from silicon-infiltrated silicon carbide
Inventor: BENKER WERNER
IPC: C04B41/88
Filed: 1991-08-08
Abstract: In order to siliconise porous mouldings of silicon carbide/carbon, a mixture of silicon carbide powder, organic binder and optionally carbon is moulded to give a green compact, the binder of the green compact is removed in a nonoxidising atmosphere by carbonisation at about 1000 DEG C and the blank obtained is siliconised by the action of molten silicon, the blank obtained resting on a porous SiSiC support whose lower part is in contact with the liquid silicon, and the arrangement of SiSiC support and resulting moulding being cooled after the end of siliconisation. The support used is a dense packing of porous SiSiC rings which are arranged parallel to one another and at right angles on a graphite combustion plate which is charged with silicon and is impermeable to liquid silicon.
Patent IE-69125-B1 (IE)
Title: Bone growth stimulator
Inventor: BAO QI-BIN
IPC: A61K9/22
Filed: 1991-08-13
Abstract: An implantable material for promoting bone growth has a microporous structure exhibiting an average pore size of at least 30  ANGSTROM . The porous biomaterial is capable of retaining macromolecules having a molecular weight of at least 15,000 and up to 500,000.
Patent IE-60695-B1 (IE)
Title: Tetrahydronaphthalene derivatives
IPC: C07D487/04
Filed: 1987-11-13
Abstract: Compounds of the formula    <IMAGE>  I  wherein R is lower-alkyl, R1 is halogen, R2 is C1-C12-alkyl, R3 is hydroxy, lower-alkoxy, lower-alkyl-carbonyloxy, lower-alkoxy-lower-alkylcarbonoyloxy, lower-alkylaminocarbonyloxy, arylaminocarbonyloxy or aryl-lower alkylaminocarbonyloxy, X is C1-C18-alkylene which optionally can be interrupted by 1,4-phenylene or interrupted or lengthened by 1,4-cyclohexylene, A is di- or tri-substituted 2-imidazolyl attached via an ethylene group or a substituted or unsubstituted heterocycle selected from the group consisting of benzimidazolyl, benzimidazolonyl, imidazo[4,5-c]pyridinyl, imidazo[4,5-c]pyridinonyl, benzthiazolyl, benzodiazepine-2,5-dion-1-yl and pyrrolo[2,1-c]-[1,4]benzodiazepine-5,11-dion-10-yl and n is the number 0 or 1, in the form of racemates and optical antipodes, as well as N-oxides and pharmaceutically usable acid addition salts thereof. The compounds of formual I have a pronounced calcium-antagonistic and anti-arrhythmic activity and can accordingly be used as medicaments, especially for the control or prevention of angina pectoris, ischaemia, arrhythmias, high blood pressure and cardiac insufficiency.
Patent IE-61959-B1 (IE)
Title: Cheese manufacture
Inventor: REDDY MALIREDDY S
IPC: A23C19/05
Filed: 1988-10-12
Abstract: The method of making cheese includes the steps of:   a) where necessary preconditioning cold, raw milk by lowering the pH to a desired level prior to heat treating;   b) heat treating the preconditioned milk; and c) post acidifying the milk prior to inoculating with a starter culture or acidogen or a slow release acidulant.   The method proceduces cheese which has more whey protein and residual fat incorporated in the cheese curd. The method can be used to make a variety of cheeses including mozzarella and cottage cheese.
Patent IE-68934-B1 (IE)
Title: Aromatase inhibiting 4 (5) - imidazoles
Inventor: KARJALAINEN ARTO JOHANNES
IPC: A61K31/415
Filed: 1991-09-20
Abstract: Novel imidazole derivatives of the formula <CHEM> wherein R1, R2, R min 1 and R min 2, which can be the same or different, are H,CH3, C2H5, C3H7, OCH3, NO2, NH2, CN, CF3, CHF2, CHF2 or halogen; R min  is H or <CHEM> where R3 is H, CH3 or halogen; R4 is H or OH and R5 is H or OH or R4 and R5 together form a bond and n is 1 to 4, and their non-toxic salts exhibit aromatase and desmolase inhibiting properties. Selective aromatase inhibiting compounds are valuable in the treatment of estrogen dependent diseases, e.g. breast cancer or benign prostatic hyperplasia (BPH).
Patent IE-80506-B1 (IE)
Title: Electrical connector with contact anti-overstress means
Inventor: WILHITE MATHEW
IPC: H01R12/71
Filed: 1992-05-08
Abstract: An anti-overstress system is provided in an electrical connector (10) which includes a dielectric housing (12) having a contact-receiving cavity (16) with a slot (18) communicating the cavity with a mating surface (20) on the outside of the housing. A contact (14) is received in the cavity and includes a cantilevered spring contact arm (26) disposed in the slot. The arm has a contacting portion (30) projecting beyond the mating surface of the housing for engagement with a complementary contact (62) of the mating connector (64). The spring contact arm flexes in the slot upon engagement of the contacting portion by the complementary contact. The anti-overstress system is provided between the contact and the housing and includes a pair of wings (48) projecting from opposite sides of the spring contact arm (26) engageable with a pair of ledges (22) formed in opposite sides of the slot (18) after a given amount of flexing of the spring contact arm.
Patent LU-100303-B1 (LU)
Title: Anti-polluting improved structure of cosmetic box
Inventor: CHEN LIZHUAN
IPC: A45D34/00
Filed: 2017-06-20
Granted: 2017-10-25
Abstract: The present invention relates to the technical field of cosmetics, and particularly to an anti-polluting improved structure of a cosmetic box. The anti-polluting improved structure of the cosmetic box comprises two cavities, and a channel is disposed between the two cavities; the channel is disposed at the bottoms of the corresponding cavities respectively; the two cavities accommodate a cosmetic fluid and a cosmetic tool for being dipped in the cosmetic fluid, and the cosmetic fluid can reach the use position of the cosmetic tool through the channel. According to the present invention, the two independent cavities are arranged to accommodate the cosmetic fluid and the cosmetic tool respectively, an extrusion device is arranged between the two cavities, a user can squeeze different amounts of cosmetic fluid as required, so that the cosmetic fluid used each time is fresh cosmetic fluid, pollution is reduced, the possibility of disease infection is reduced, and the cosmetic fluid is further saved.
Patent LU-101579-B1 (LU)
Title: Filter und Vorrichtung zum Entfernen von Verschmutzungen aus einer Flüssigkeit, insbesondere zum Entfernen von mikro- und nanoskaligen Kunststoffpartikeln aus Wasser, Verfahren zur Herstellung eines solchen Filters sowie dessen Verwendung
Inventor: AHMAD FÄHZAN
IPC: C02F1/00
Filed: 2019-12-20
Granted: 2021-06-21
Abstract: Die Erfindung betrifft ein Filter (1; Ib; Ic) sowie eine Vorrichtung (12; 12c) zum Entfernen von Verschmutzungen (6; 6a) aus einer Flüssigkeit, insbesondere zum Entfernen von mikro- und nanoskaligen Kunststoffpartikeln aus Wasser. Zweckmäßigerweise ist das mindestens eine Filtermaterial (3; 3a; 3c) wenigstens teilweise mit einer die Verschmutzungen (6; 6a) aufnehmenden Schicht (5; 9; 39) belegt. Vorteilhaft ist eine Flüssigkeitsreinigung ohne Entfernen von als Ionen vorliegenden Mineralstoffen möglich. Lediglich für ein Lebewesen schädliche Verschmutzungen werden entfernt. Wird Wasser mit einem erfindungsgemäßen Filter gereinigt, wird dessen von den Ionen und Mineralstoffen bestimmter Geschmack vorteilhaft nicht verändert.
Patent LU-504714-B1 (LU)
Title: Evaluation Method and Device for Performance of Wind Turbine Generator System
Inventor: BU JIANGTAO
IPC: G06F30/20
Filed: 2023-07-11
Granted: 2024-01-11
Abstract: The invention discloses an evaluation method and device for performance of wind turbine generator system, wherein the evaluation method and device for performance of wind turbine generator system comprises the following steps: acquiring operation data of the wind turbine generator system within a period of time; calculating the operation data to obtain a power curve of the wind turbine generator system; synthesizing the performance indexes of all power generation sections to determine the comprehensive performance index; and evaluating the performance of the wind turbine generator system according to the comprehensive performance index. According to the invention, the performance index of each power generation section is calculated according to the key wind speed points on the basis of the power curve, so that the accuracy of performance evaluation of the wind turbine generator system is ensured.
Patent NO-304406-B1 (NO)
Inventor: BUXTON IAN RICHARD
IPC: A61K9/26
Filed: 1992-08-11
Abstract: A controlled release composition comprising spheroid cores consisting of diltiazem or a pharmaceutically acceptable salt thereof and optionally a spheronising agent, said cores being coated with a controlled release layer. The spheronising agent when present is preferably microcrystalline cellulose. Ethylcellulose is a preferred controlled release coating. The controlled release coating preferably contains a plasticiser, a surfactant and a tack-modifier.
Patent NO-302033-B1 (NO)
Inventor: CUFFIANI ILLARO
IPC: C08F10/00
Filed: 1993-12-09
Abstract: The present invention relates to a process for the preparation of homopolymers and copolymers of ethylene having a broad molecular weight distribution. The polymerisation is carried out in the presence of catalysts comprising the product of reaction between an alkyl-Al compound and a solid catalytic component comprising a titanium compound supported on a magnesium halide in an active form, having a spherical morphology and particular surface and porosity characte-ristics.
Patent NO-307602-B1 (NO)
Inventor: FISHER LUKE
IPC: B65D47/20
Filed: 1994-11-30
Abstract: A wash bottle (10) for dispensing solvent comprises a squeezable plastics container (12) with a cap (16). A syphon tube (36) extends from near the bottom of the container to a nozzle (20) extending through the cap. As a continuation of the syphon tube is a valve body (34), whereby pressure above the solvent can be relieved and which closes when the bottle is squeezed for solvent to be dispensed via the syphon tube and nozzle. <IMAGE>
Patent NO-308540-B1 (NO)
Inventor: AORILO JARI
IPC: C08F255/00
Filed: 1995-06-28
Abstract: PCT No. PCT/FI93/00544 Sec. 371 Date Jun. 30, 1995 Sec. 102(e) Date Jun. 30, 1995 PCT Filed Dec. 17, 1993 PCT Pub. No. WO94/15981 PCT Pub. Date Jul. 21, 1995A method for modifying polyolefins by grafting with a carboxylic acid, carboxylic acid anhydride or other functionalized monomer in the presence of two additional comonomers, one being an aliphatic diolefin and the other an aromatic vinyl or (meth)acrylate monomer.
Patent NO-318266-B1 (NO)
Inventor: WIDEN BO
IPC: E05B19/00
Filed: 1996-06-24
Abstract: A cylinder lock and key combination, wherein the lock comprises a side profile ridge (60) disposed in the key slot (53) and having a relatively shallow recess (61), in which a projection (55) on a side tumbler (54) is vertically movable, and a continuously extending edge portion (62). The key has a relatively shallow coded groove (17), which cooperates with the side tumbler projections (55) of the lock, and a rectilinear, deeper profile groove (16), into which the edge portion (62) of the side profile ridge fits. This unitary edge portion secures a good guidance of the key when the latter is inserted into the lock.
Patent NO-319376-B1 (NO)
Inventor: SYMONDS GEOFFREY P
IPC: A61P31/12
Filed: 1996-07-04
Abstract: The present invention concerns an oligonucleotide compound, which comprises a ribozyme targeted to the GUA target site at nucleotide 5849 of the HIV-1 SF-2 isolate or a corresponding target site of other HIV-1 isolates. The invention also relates to transfer vectors comprised of RNA or DNA or a combination thereof which on transcription give rise to said compound, to cells comprising a nucleotide sequence which is, or on transcription gives rise to, said compound and to pharmaceutical compositions containing said compound or said transfer vector. <IMAGE>